Haoxi Health COO reports 214,400 share holding

Haoxi Health Technology Ltd director and Chief Operating Officer Xu Lei LX reported their holdings in the company.

Accepted by SEC EDGAR 04/06/2026 - 10:25 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Haoxi Health Technology Ltd director and Chief Operating Officer Xu Lei LX reported their holdings in the company. The Form 3 filing shows direct ownership of 214,400 Class A ordinary shares of Haoxi Health Technology Ltd, reflecting the executive’s initial reported equity position in the issuer.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Xu Lei LX

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Holding	Class A ordinary shares, par value US$0.0025 each	--	--	--

Holdings: Class A ordinary shares, par value US$0.0025 each — 214,400 shares (Direct)

Key Figures

Shares held: 214,400 shares Par value per share: US$0.0025 per share

2 metrics

Shares held 214,400 shares Class A ordinary shares directly held by Xu Lei LX after reported holding

Par value per share US$0.0025 per share Par value of Haoxi Health Technology Ltd Class A ordinary shares

Key Terms

Class A ordinary shares, par value, Chief Operating Officer

3 terms

Class A ordinary shares financial

"Class A ordinary shares, par value US$0.0025 each"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

par value financial

"Class A ordinary shares, par value US$0.0025 each"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

Chief Operating Officer financial

"officer_title": "Chief Operating Officer""

A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Haoxi Health Technology Ltd (HAO) shares does Xu Lei LX hold?

Xu Lei LX directly holds 214,400 Class A ordinary shares of Haoxi Health Technology Ltd. This holding is reported in a Form 3 filing, which details the executive’s equity position as a director and Chief Operating Officer of the company.

What role does Xu Lei LX hold at Haoxi Health Technology Ltd (HAO)?

Xu Lei LX is reported as a director and Chief Operating Officer of Haoxi Health Technology Ltd. This senior leadership role is disclosed alongside the executive’s direct ownership of 214,400 Class A ordinary shares in the Form 3 insider filing.

What type of security does Xu Lei LX own in Haoxi Health Technology Ltd (HAO)?

Xu Lei LX owns Class A ordinary shares, each with a par value of US$0.0025, in Haoxi Health Technology Ltd. The Form 3 filing states a total direct holding of 214,400 of these Class A ordinary shares in the issuer.

Is Xu Lei LX’s ownership in Haoxi Health Technology Ltd (HAO) direct or indirect?

The ownership reported for Xu Lei LX in Haoxi Health Technology Ltd is direct. The Form 3 data classifies the 214,400 Class A ordinary shares as directly held, with the ownership type marked with the code “D” for direct ownership.

Does the Haoxi Health Technology Ltd (HAO) Form 3 show any recent share transactions?

The Form 3 data for Haoxi Health Technology Ltd shows Xu Lei LX’s holdings rather than explicit buy or sell transactions. Transaction fields indicate an unknown transaction code and classify the entry as a holding, with 214,400 shares held following the reported position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Xu Lei LX

(Last) (First) (Middle)

ROOM 902, UNIT 1, 9TH FLOOR

NO.6A CHAOYANGMENWAI STREET

(Street)

BEIJING BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A ordinary shares, par value US$0.0025 each	214,400	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Lei Xu	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)